Evidence map›Paper›PMID 40138394›Full record

ArticleScience advances2025

NAT10 and

Turja K Debnath, Nathan S Abell, Yi-Ru Li, Sravan K Devanathan, Enrique Navedo, Blerta Xhemalçe

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Nat10-mediated acScience China. Life sciences · 2026
    Article
  5. Review
  6. NAT10-dependent NCell reports · 2026
    Article
  7. Review
  8. YY1 Interacts with Promoter R-Loops to Regulate Transcription.Journal of the American Chemical Society · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Turja K DebnathDepartment of Molecular Biosciences, University of Texas at Austin, 2500 Speedway, Austin, TX 78712, USA.ORCID 0000-0003-2021-4690
Nathan S AbellDepartment of Molecular Biosciences, University of Texas at Austin, 2500 Speedway, Austin, TX 78712, USA.ORCID 0000-0003-1098-5395
Yi-Ru LiDepartment of Molecular Biosciences, University of Texas at Austin, 2500 Speedway, Austin, TX 78712, USA.ORCID 0009-0004-3173-125X
Sravan K Devanathan
Enrique Navedo
Blerta XhemalçeDepartment of Molecular Biosciences, University of Texas at Austin, 2500 Speedway, Austin, TX 78712, USA.ORCID 0000-0002-0517-9607

Funding

Elucidating mechanisms of microRNA pathway deregulation in human cellsR01GM127802 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI XHEMALCE, BLERTA · 2018 to 2022
$1.7M
NIGMS NIH HHS R01 GM127802
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetyltransferasesCytidineInflammationAcetylationHumansN-Terminal AcetyltransferasesNucleic Acid ConformationRNA, TransferAcetyltransferasesCytidineN-acetylcytidineNAT10 protein, humanN-Terminal AcetyltransferasesRNA, Transfer

Identifiers

PMID40138394
PMCPMC11939041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.